Incyte Announces Positive Phase 3 Results for Vitiligo cream
Primary and key secondary endpoints met in both TRuE-V1 and TRuE-V2 studies Data will support planned ...
Read more
Tag: Incyte
US FDA extend review period of the supplemental NDA for baricitinib of Eli Lilly and Incyte
Eli Lilly and Company and Incyte announced that the U.S. Food and Drug Administration (FDA) has ...
Read more
Incyte Announces the European Commission Approval of Pemazyre® (pemigatinib) as a Treatment for Locally Advanced or Metastatic Cholangiocarcinoma
Incyte today announced that the European Commission (EC) has approved Pemazyre® (pemigatinib) for the treatment of adults ...
Read more
Incyte Announces Approval of Pemazyre® (pemigatinib) in Japan
Incyte today announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Pemazyre® ...
Read more